Cooperative Agreement UG3EB036467
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $413,067 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Colorado State University to develop a new class of electrochemical biosensors that use engineered binding proteins. The goal is to simplify fabrication and improve performance of electrochemical sensors, which have potential for inexpensive, sensitive, and quantitative...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $359,995 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Clemson University. The funding supports the development and validation of a novel X-ray visualized immunosensor (X-VIS) that can be attached to implanted medical devices to detect and monitor local infection biomarkers. The project aims to fabricate a...
- This $360,320 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop and test the first continuous electrochemical sensors for monitoring large protein and peptide analytes, such as insulin and cardiac markers. The project, titled "Aptamer Tagging with Redox Quenchers: A Critical Breakthrough in the Sensitivity of...
- This Project Grant award for $299,712 from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the development of electrochemical aptamer-based (E-AB) sensors for the rapid and accurate detection of multiple cardiovascular disease (CVD) biomarkers. The University of South Carolina, with mentorship from collaborators at the University of Cincinnati, will design and characterize these multiplexed E-AB sensors to enable early diagnosis of CVDs, which are...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $424,500 Cooperative Agreement to North Carolina Central University (NCCU) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The funding will enable NCCU to expand its Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) program, establishing a Biotechnology Makerspace with advanced bioprinting and imaging resources. This will...
- This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) award of $1,200,000 provides funding to the University of California, Berkeley from October 1, 2024 to September 30, 2028 to develop innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this project grant are to: (1) develop molecular engineering techniques using DNA origami...
- The National Science Foundation awarded Integrated Medical Sensors Inc. a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel multi-analyte microsensor platform for continuous wireless monitoring applications. The grant aims to create a unique monolithic semiconductor platform capable of wirelessly monitoring multiple biochemical and physiological markers simultaneously in a sub-cubic millimeter footprint. This miniature,...
- The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
- This Cooperative Agreement award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $536,496.00 to the Regents of the University of Michigan to develop an injectable scaffold system for early detection of immune dysregulation and monitoring response to immunotherapies. The project aims to create a "living sentinel" that can monitor...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $374,378 to Michigan State University to develop a computational modeling framework for a miniaturized, noninvasive, wireless, luminescence-based carbon dioxide sensing wearable device. The goal is to accurately translate transcutaneous partial pressure of CO2...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $446,199 Cooperative Agreement under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Winston-Salem State University (WSSU) and partner institutions. The project aims to develop a multimodal sensor platform using advanced nanomaterials and detection technologies to enable simultaneous, rapid, and accurate measurement of multiple hormone biomarkers such as cortisol, cortisone, and insulin at physiological concentrations. The initial goals are to assess the utility of this novel approach for improving the sensitivity, specificity, and accuracy of biomarker detection, which is critically important for enhancing the diagnosis of numerous human diseases. The project will involve an initial characterization of the sensing platforms, followed by development and optimization of functionalized biochemicals that can bind to the target biomarkers. WSSU will collaborate with multiple partner institutions through sub-awards to execute this research and development effort, which is scheduled for completion by June 30, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $446.2k | 7/25/25 |